scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1007710492 |
P356 | DOI | 10.1186/S13046-016-0350-Y |
P932 | PMC publication ID | 4855705 |
P698 | PubMed publication ID | 27141829 |
P2093 | author name string | Wei Chen | |
Jie Li | |||
Xu Li | |||
Lijie Wang | |||
Xia Zheng | |||
Le Zhao | |||
He Chen | |||
Jiaojiao Lu | |||
Xi Han | |||
Huilian Hou | |||
Zhongxue Ye | |||
P2860 | cites work | Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 | Q24306181 |
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 | Q24316558 | ||
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine | Q24614582 | ||
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies | Q24648438 | ||
The basics of epithelial-mesenchymal transition | Q24652992 | ||
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention | Q26864839 | ||
Targeting TGF-β signaling in cancer | Q27012443 | ||
Cancer statistics, 2015 | Q27860576 | ||
TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence | Q28477306 | ||
Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification | Q28504641 | ||
Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine | Q28585429 | ||
Cancer epigenetics: from mechanism to therapy | Q29614799 | ||
X inactivation, differentiation, and DNA methylation | Q33999850 | ||
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation | Q34258768 | ||
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma | Q34299814 | ||
TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases | Q34301250 | ||
NANOG-dependent function of TET1 and TET2 in establishment of pluripotency | Q34327015 | ||
Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis | Q34590225 | ||
Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence. | Q34762217 | ||
TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma | Q35273414 | ||
Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer. | Q35749302 | ||
Global profiling of DNA methylation erasure in mouse primordial germ cells | Q35864711 | ||
TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells | Q36213724 | ||
Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells | Q36934066 | ||
miR-29 represses the activities of DNA methyltransferases and DNA demethylases | Q37091993 | ||
Ten-eleven translocation (Tet) and thymine DNA glycosylase (TDG), components of the demethylation pathway, are direct targets of miRNA-29a | Q37157046 | ||
MicroRNA-26a targets ten eleven translocation enzymes and is regulated during pancreatic cell differentiation | Q37276461 | ||
An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis | Q37327706 | ||
miR-30d Blocked Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells | Q38824925 | ||
TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression | Q38832692 | ||
TET3 mediates the activation of human hepatic stellate cells via modulating the expression of long non-coding RNA HIF1A-AS1. | Q38924188 | ||
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas | Q39333118 | ||
miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling | Q39413020 | ||
Involvement of miRNA-29a in epigenetic regulation of transforming growth factor-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma. | Q53101387 | ||
TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). | Q55036452 | ||
DNA modification mechanisms and gene activity during development | Q66907977 | ||
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | 72 | |
P577 | publication date | 2016-05-04 | |
P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
P1476 | title | TET3 inhibits TGF-β1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells | |
P478 | volume | 35 |
Q91717197 | Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma |
Q47303229 | CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma |
Q89514240 | Epigenetic induction of tumor stemness via the lipopolysaccharide-TET3-HOXB2 signaling axis in esophageal squamous cell carcinoma |
Q90630066 | Expression and prognosis analysis of TET family in acute myeloid leukemia |
Q90705372 | Glyphosate Primes Mammary Cells for Tumorigenesis by Reprogramming the Epigenome in a TET3-Dependent Manner |
Q37221246 | Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma |
Q64227434 | Methylation and ovarian cancer: Can DNA methylation be of diagnostic use? |
Q58788954 | MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis |
Q92221539 | Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials |
Search more.